Results 101 to 110 of about 73,068 (324)
Choroidal Paraganglioma with Metastases to the Fellow Eye
Purpose: To report a case of a paraganglioma in the right eye with metastatic disease in the fellow eye 3 years later. Methods: A 70-year-old man presented with a painful amblyopic right eye; rubeosis iridis and a large choroidal tumor were found.
Rita Van Ginderdeuren +2 more
doaj +1 more source
Introduction Bladder paraganglioma is exceedingly rare, accounting for
Toshifumi Takahashi +6 more
doaj +1 more source
Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report [PDF]
BackgroundRecent advance of genetic testing has contributed to the diagnosis of hereditary pheochromocytoma and paraganglioma (PPGL). The clinical characteristics of hereditary PPGL are varying among the types of mutational genes.
Adachi Yayoi +13 more
core +2 more sources
Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma [PDF]
Liang Zhang +6 more
openalex +1 more source
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley +1 more source
Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues. [PDF]
Anti-angiogenic therapies are an important class of anti-cancer treatment drugs. However, their efficacy is limited to certain tumors and would benefit from identifying a biomarker predictive of therapeutic response.
Boichard, Amélie +2 more
core
Új módszertani lehetőségek és ezek alkalmazása a hormonális rendszer daganatainak genetikai kivizsgálásában [PDF]
The technical developments leading to revolution in clinical genetic testing offer new approaches for patients with cancer. From one mutation or one gene approach the scale of genetic testing moved to whole exome or whole genome scale.
Baghy K, +4 more
core +1 more source
Genotype-phenotype correlations in pheochromocytoma and paraganglioma.
Pheochromocytoma and paraganglioma (PPGL) can be divided into at least four molecular subgroups. Whether such categorizations are independent factors for prognosis or metastatic disease is unknown.
J. Crona +5 more
semanticscholar +1 more source
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley +3 more
wiley +1 more source
Background Neurofibromatosis type 1 has a higher prevalence of pheochromocytoma and paraganglioma than the general population: 1.0–5.7% versus 0.2–0.6%.
Juan Wang +3 more
doaj +1 more source

